Carl Zeiss Meditec AG/ DE0005313704 /
| 08/11/2024 17:25:29 | Chg. - | Volume | Bid30/09/2024 | Ask19/07/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 58.13EUR | - | 1,660 Turnover: 96,121.05 |
-Bid Size: - | -Ask Size: - | 5.32 bill.EUR | 1.85% | 18.31 |
Assets
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 116.8000 | 135.3000 | 199.6000 | 236.1500 | 315.8000 | ||||||
| Intangible Assets | 144.3000 | 137.4000 | 153.7000 | 240.4300 | 259.5000 | ||||||
| Long-Term Investments | - | - | - | - | 8.6000 | ||||||
| Fixed Assets | 717.8000 | 720.5000 | 792 | 1,030.9600 | 1,121.2000 | ||||||
| Inventories | 268.3000 | 286.4000 | 286.4000 | 382.7500 | 520.2000 | ||||||
| Accounts Receivable | 205.8000 | 165.2000 | 185.9000 | 197.8000 | 196.6000 | ||||||
| Cash and Cash Equivalents | 22.6000 | 5.2000 | 7.4000 | 7.7300 | 10.6000 | ||||||
| Current Assets | 1,304.3000 | 1,289.5000 | 1,604 | 1,791.8500 | 1,911.7000 | ||||||
| Total Assets | 2,022.1000 | 2,013.3000 | 2,396 | 2,822.8200 | 3,032.9000 | ||||||
Liabilities
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 83.5000 | 55.1000 | 98.2000 | 124.3900 | 157.8000 | ||||||
| Long-term debt | 109 | 87.5000 | 76.5000 | 91.7700 | 229.9000 | ||||||
| Liabilities to Banks | 129.1000 | 107.9000 | 148.2000 | - | - | ||||||
| Provisions | 51.2000 | 44 | 42.7000 | 29.3100 | 71.6000 | ||||||
| Liabilities | 605.2000 | 562.7000 | 718.6000 | 792.7300 | 860.0100 | ||||||
| Share Capital | 89.4410 | 89.4410 | 89.4410 | - | - | ||||||
| Total Equity | 1,398.4000 | 1,431.7000 | 1,659.3000 | 2,015.1000 | 2,159.4000 | ||||||
| Minority Interests | 18.5000 | 18.8000 | 18.1000 | 14.9900 | 13.5000 | ||||||
| Total liabilities equity | 2,022.1000 | 2,013.3000 | 2,396 | 2,822.8200 | 3,032.9000 | ||||||
Income Statement
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,459.3000 | 1,335.5000 | 1,646.8000 | 1,902.8400 | 2,089.3000 | ||||||
| Depreciation (total) | - | - | - | 69.7700 | - | ||||||
| Operating Result | 264.7000 | 177.6000 | 373.6000 | 396.8800 | 348.1000 | ||||||
| Interest Income | -5.9000 | -25.8000 | -7 | 4.1500 | 12.8000 | ||||||
| Income Before Taxes | 229.9000 | 178.7000 | 339.1000 | 403.4900 | 412.6000 | ||||||
| Income Taxes | 69.3000 | 55.3000 | 101.5000 | 107.5800 | 120.6000 | ||||||
| Minority Interests Profit | -.8000 | -1 | -1.2000 | -2 | -1.6000 | ||||||
| Net Income | 159.8000 | 122.4000 | 236.3000 | 293.9000 | 290.4000 | ||||||
Per Share
Cash Flow
|
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
2023 IFRS in mill. EUR |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 219.6000 | 178.5000 | 362.7000 | 188.2000 | 250.9000 | ||||||
| Cash Flow from Investing Activities | -145.8000 | -71.9000 | -75.2000 | -148.8900 | -111 | ||||||
| Cash Flow from Financing | -58.6000 | -123 | -285.9000 | -38.2400 | -135.1000 | ||||||
| Decrease / Increase in Cash | 16 | -17.4000 | 1.2000 | - | - | ||||||
| Employees | 3,232 | 3,290 | 3,531 | 4,224 | 4,823 | ||||||
